Paediatrics & child health最新文献_第5页

Les soins aux enfants et aux adolescents ayant la paralysie cérébrale (aux niveaux III à V du GMFCS) 护理脑瘫儿童和青少年（GMFCS III 至 V 级）

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-05-31 DOI: 10.1093/pch/pxae004

Scott McLeod, Amber Makino, Anne Kawamura

Résumé La paralysie cérébrale (PC) est l’incapacité physique la plus fréquente chez les enfants canadiens. Les soins complets des enfants ayant la PC, qui sont capables de marcher et qui fonctionnent aux niveaux I et II du système de classification de la fonction motrice globale (GMFCS) sont déjà exposés dans un point de pratique. Le présent document complémentaire traite des soins aux enfants ayant la PC qui fonctionnent aux niveaux III à V du GMFCS. Ceux qui fonctionnent aux niveaux III et IV du GMFCS utilisent des dispositifs d’assistance comme des déambulateurs, des cannes ou des aides à la mobilité motorisées, tandis que ceux qui fonctionnent au niveau V du GMFCS ont besoin d’assistance à la mobilité comme un fauteuil roulant manuel. Le présent document contient un aperçu des principaux concepts relatifs à la détection précoce, aux services de réadaptation et aux possibilités de traitement pour les enfants présentant ces niveaux de PC, conjointement avec des ressources pratiques pour contribuer à la surveillance de la santé assurée par les pédiatres qui s’occupent de cette population.

摘要脑瘫（CP）是加拿大儿童中最常见的肢体残疾。实践要点中已经概述了对能够行走且功能处于粗大运动功能分级系统（GMFCS）I级和II级的CP患儿的全面护理。本补充文件将介绍如何护理功能处于GMFCS三级至五级的CP患儿。功能处于GMFCS III和IV级的儿童需要使用助行器、手杖或电动助行器等辅助器具，而功能处于GMFCS V级的儿童则需要手动轮椅等助行器具。本文件概述了与这些CP水平的儿童的早期检测、康复服务和治疗方案有关的关键概念，并提供了实用资源，以协助儿科医生对这一人群进行健康监测。

{"title":"Les soins aux enfants et aux adolescents ayant la paralysie cérébrale (aux niveaux III à V du GMFCS)","authors":"Scott McLeod, Amber Makino, Anne Kawamura","doi":"10.1093/pch/pxae004","DOIUrl":"https://doi.org/10.1093/pch/pxae004","url":null,"abstract":"Résumé La paralysie cérébrale (PC) est l’incapacité physique la plus fréquente chez les enfants canadiens. Les soins complets des enfants ayant la PC, qui sont capables de marcher et qui fonctionnent aux niveaux I et II du système de classification de la fonction motrice globale (GMFCS) sont déjà exposés dans un point de pratique. Le présent document complémentaire traite des soins aux enfants ayant la PC qui fonctionnent aux niveaux III à V du GMFCS. Ceux qui fonctionnent aux niveaux III et IV du GMFCS utilisent des dispositifs d’assistance comme des déambulateurs, des cannes ou des aides à la mobilité motorisées, tandis que ceux qui fonctionnent au niveau V du GMFCS ont besoin d’assistance à la mobilité comme un fauteuil roulant manuel. Le présent document contient un aperçu des principaux concepts relatifs à la détection précoce, aux services de réadaptation et aux possibilités de traitement pour les enfants présentant ces niveaux de PC, conjointement avec des ressources pratiques pour contribuer à la surveillance de la santé assurée par les pédiatres qui s’occupent de cette population.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"38 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141193862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Childhood dyslipidemia: Clinician management practices in the primary care setting 儿童血脂异常：初级保健中的临床医生管理方法

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-05-29 DOI: 10.1093/pch/pxae018

Katherine N Tom, Alicia M Polack, Natasha D De Silva, Jonathan P Wong, Charles D G Keown-Stoneman, Jonathon L Maguire, Catherine S Birken, Peter D Wong

Objectives To describe clinician management practices for childhood dyslipidemia in the community setting. Methods A descriptive study was conducted for children aged 2 to 10 years with dyslipidemia as defined by the National Cholesterol Education Program Expert Panel on Cholesterol in Children criteria. A convenience sample of participants from the TARGet Kids! cohort study (Toronto, Canada) was used. Trained research assistants reviewed participant medical records to document clinician management practices of abnormal lipid levels. The study outcome was the proportion of clinicians engaging in each management practice. Descriptive statistics were completed, reporting the proportion of clinician engagement in management practices. Results All 768 children were seen by primary paediatric care providers after lipid levels identified dyslipidemia. Medical history regarding lifestyle behaviours and cardiovascular risk factors were frequently obtained (n = 565, 73.6%). Physicians rarely informed families about abnormal lipid levels (n = 11, 1.43%). Management plans for abnormal lipid levels were rarely documented (n = 4, 0.5%). Clinicians did not refer to paediatric lipid specialists or initiate statin therapy. Conclusions Paediatric care providers rarely identified and initiated early management for abnormal lipid levels. Our results may inform the need for improved knowledge translation of the recently published Canadian clinical practice update for the detection and management of childhood dyslipidemia.

目的描述临床医生在社区环境中处理儿童血脂异常的方法。方法根据美国国家胆固醇教育计划儿童胆固醇专家小组的标准，对患有血脂异常的 2-10 岁儿童进行描述性研究。研究采用方便抽样法，从 TARGet Kids！队列研究（加拿大多伦多）的参与者中抽取样本。经过培训的研究助理查阅了参与者的医疗记录，记录了临床医生对血脂异常的处理方法。研究结果是临床医生采用每种管理方法的比例。研究人员完成了描述性统计，报告了临床医生参与管理措施的比例。结果所有 768 名儿童均在血脂水平确定为血脂异常后接受了初级儿科医疗服务提供者的诊治。医生经常询问有关生活方式和心血管风险因素的病史（565 人，73.6%）。医生很少将血脂异常告知家属（11 人，1.43%）。很少记录血脂异常的管理计划（4 人，0.5%）。临床医生未将患者转诊至儿科血脂专家或启动他汀类药物治疗。结论儿科医疗服务提供者很少发现血脂异常并启动早期管理。我们的研究结果可能表明，需要对最近发布的加拿大临床实践更新版进行更好的知识转化，以检测和管理儿童血脂异常。

{"title":"Childhood dyslipidemia: Clinician management practices in the primary care setting","authors":"Katherine N Tom, Alicia M Polack, Natasha D De Silva, Jonathan P Wong, Charles D G Keown-Stoneman, Jonathon L Maguire, Catherine S Birken, Peter D Wong","doi":"10.1093/pch/pxae018","DOIUrl":"https://doi.org/10.1093/pch/pxae018","url":null,"abstract":"Objectives To describe clinician management practices for childhood dyslipidemia in the community setting. Methods A descriptive study was conducted for children aged 2 to 10 years with dyslipidemia as defined by the National Cholesterol Education Program Expert Panel on Cholesterol in Children criteria. A convenience sample of participants from the TARGet Kids! cohort study (Toronto, Canada) was used. Trained research assistants reviewed participant medical records to document clinician management practices of abnormal lipid levels. The study outcome was the proportion of clinicians engaging in each management practice. Descriptive statistics were completed, reporting the proportion of clinician engagement in management practices. Results All 768 children were seen by primary paediatric care providers after lipid levels identified dyslipidemia. Medical history regarding lifestyle behaviours and cardiovascular risk factors were frequently obtained (n = 565, 73.6%). Physicians rarely informed families about abnormal lipid levels (n = 11, 1.43%). Management plans for abnormal lipid levels were rarely documented (n = 4, 0.5%). Clinicians did not refer to paediatric lipid specialists or initiate statin therapy. Conclusions Paediatric care providers rarely identified and initiated early management for abnormal lipid levels. Our results may inform the need for improved knowledge translation of the recently published Canadian clinical practice update for the detection and management of childhood dyslipidemia.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"24 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141193856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Automatic urine cultures from catheter-obtained samples—time to implement a practice change to improve value 从导管获取的样本中自动进行尿液培养--实施实践变革以提高价值的时间

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-05-29 DOI: 10.1093/pch/pxae021

Inbal Kestenbom, Neta Cohen, Gidon Test, Aaron Campigotto, Michelle Science, Olivia Ostrow

Objectives Urine cultures are often automatically obtained after urinary catheterization in young children, even in the absence of pyuria, to test for urinary tract infections (UTIs). Although this practice conflicts with some newer guidelines, it is frequently followed in busy emergency departments (EDs) to minimize the need for a repeat invasive procedure. To assess the implications of this longstanding practice, we aimed to describe the frequency and characteristics of children with normal urinalysis (UA) and positive urine culture obtained via catheterization, and to describe their clinical course. Methods A single center, retrospective cohort study was performed for otherwise healthy children aged 6 to 24 months, presenting to a Pediatric ED between January and June 2019 who underwent UTI testing via a urine catheterization. The point-of-care (POC) UA and urine culture results along with any follow-up phone call documentation were reviewed and analyzed using descriptive statistics. Results Of the 818 urine cultures obtained via catheterization during the 6-month study period, 131 (16%) cultures were reported as positive. Of these positive cultures, 14 (10.7%) of the patients meeting inclusion criteria had a normal POC UA. In follow-up phone calls after the ED visit, the majority of these 14 patients were asymptomatic without any antibiotic treatment and 3 (2.3%) patients were still febrile and classified as a potentially missed UTI. Conclusions The routine practice of sending urine cultures from all catheterized urine samples in children 6 to 24 months, regardless of POC UA results, rarely detect missed UTIs. In alignment with more recent practice guidelines, this practice should be reconsidered in low-risk children seen in EDs to improve overall care quality and resource utilization.

目的幼童导尿后，即使没有脓尿，也会自动进行尿培养，以检测尿路感染 (UTI)。尽管这种做法与一些较新的指南相冲突，但在繁忙的急诊科（ED）中仍经常采用，以尽量减少重复侵入性操作的需要。为了评估这种长期存在的做法的影响，我们旨在描述通过导尿获得正常尿液分析（UA）和尿培养阳性结果的儿童的频率和特征，并描述他们的临床病程。方法我们在单中心开展了一项回顾性队列研究，研究对象为 2019 年 1 月至 6 月期间到儿科急诊室就诊的 6 至 24 个月大的健康儿童，他们都通过导尿管进行了 UTI 检测。研究人员使用描述性统计方法对护理点 (POC) 尿液分析和尿培养结果以及任何后续电话记录进行了回顾和分析。结果在为期 6 个月的研究期间，通过导尿管获得了 818 份尿培养结果，其中 131 份（16%）培养结果呈阳性。在这些阳性培养结果中，14 名（10.7%）符合纳入标准的患者的 POC UA 正常。在急诊室就诊后的电话随访中，这 14 名患者中的大多数无症状，未接受任何抗生素治疗，3 名（2.3%）患者仍在发热，被归类为可能漏诊的 UTI。结论无论 POC UA 结果如何，常规做法是将所有 6-24 个月儿童的导管尿液样本送检尿培养，但这种做法很少能发现漏检的 UTI。根据最新的实践指南，在急诊室就诊的低风险儿童应重新考虑这一做法，以提高整体护理质量和资源利用率。

{"title":"Automatic urine cultures from catheter-obtained samples—time to implement a practice change to improve value","authors":"Inbal Kestenbom, Neta Cohen, Gidon Test, Aaron Campigotto, Michelle Science, Olivia Ostrow","doi":"10.1093/pch/pxae021","DOIUrl":"https://doi.org/10.1093/pch/pxae021","url":null,"abstract":"Objectives Urine cultures are often automatically obtained after urinary catheterization in young children, even in the absence of pyuria, to test for urinary tract infections (UTIs). Although this practice conflicts with some newer guidelines, it is frequently followed in busy emergency departments (EDs) to minimize the need for a repeat invasive procedure. To assess the implications of this longstanding practice, we aimed to describe the frequency and characteristics of children with normal urinalysis (UA) and positive urine culture obtained via catheterization, and to describe their clinical course. Methods A single center, retrospective cohort study was performed for otherwise healthy children aged 6 to 24 months, presenting to a Pediatric ED between January and June 2019 who underwent UTI testing via a urine catheterization. The point-of-care (POC) UA and urine culture results along with any follow-up phone call documentation were reviewed and analyzed using descriptive statistics. Results Of the 818 urine cultures obtained via catheterization during the 6-month study period, 131 (16%) cultures were reported as positive. Of these positive cultures, 14 (10.7%) of the patients meeting inclusion criteria had a normal POC UA. In follow-up phone calls after the ED visit, the majority of these 14 patients were asymptomatic without any antibiotic treatment and 3 (2.3%) patients were still febrile and classified as a potentially missed UTI. Conclusions The routine practice of sending urine cultures from all catheterized urine samples in children 6 to 24 months, regardless of POC UA results, rarely detect missed UTIs. In alignment with more recent practice guidelines, this practice should be reconsidered in low-risk children seen in EDs to improve overall care quality and resource utilization.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141193922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Investigating the effect of virtual reality glasses during inhaler therapy use in children: A randomized clinical trial 研究虚拟现实眼镜在儿童使用吸入器治疗过程中的效果：随机临床试验

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-05-29 DOI: 10.1093/pch/pxae020

Berker Okay, Zeynep Üze Okay

Objectives Virtual reality (VR) glasses have been used in the medical field, as they are perceived to be suitable for distracting children. In this study, we aimed to compare patients who received inhaler treatment with VR glasses with those who received treatment without the aid of any device in terms of treatment compliance. Materials and Methods A prospective, randomized controlled study was conducted on pediatric patients aged 2 to 5 years requiring inhaler treatment (salbutamol), with the informed consent of their families. Participating patients who received standard care were divided into three groups via randomization: roller coaster VR group, wild dolphin VR group, and no additional device group. The patients were observed during their 15-minute inhaler treatment, and the groups were compared in terms of crying times, pre- and post-treatment physician and family questionnaire data (Face, Legs, Activity, Cry, Consolabity Scale [FLACC], Modified Yale Anxiety Scale [MYPAS], Modifiye Parents’ Pain Measure [MPMM], Wong–Baker Faces Pain Rating Scale [WBS]), and respiratory rate (RR), peripheral oxygen saturation, and heart rate value changes to determine any differences between them. Results Post-treatment questionnaire scores, RR, crying duration, and efficacy of treatment exhibited significant differences in Groups 1 and 2 compared to the control group. A significant difference was found in the post-treatment RR between groups 1 and 2, but no difference was observed in the other parameters. Conclusions Utilizing VR glasses during inhaler therapy has the potential to minimize adverse effects, such as pain, and enhance the overall comfort of the treatment environment for patients.

目的虚拟现实（VR）眼镜已被用于医疗领域，因为人们认为它适合分散儿童的注意力。在本研究中，我们旨在比较使用 VR 眼镜接受吸入器治疗的患者与不借助任何设备接受治疗的患者在治疗依从性方面的差异。材料与方法在征得家属知情同意后，我们对需要接受吸入器治疗（沙丁胺醇）的 2 至 5 岁儿童患者进行了一项前瞻性随机对照研究。接受标准治疗的参与研究的患者被随机分为三组：过山车 VR 组、野生海豚 VR 组和无附加装置组。在 15 分钟的吸入器治疗过程中观察患者的哭闹时间、治疗前后医生和家属的问卷数据（脸部、腿部、活动、哭闹、安慰量表[FLACC]、修正的耶鲁焦虑量表[MYPAS]、修正的父母疼痛量表[MPMM]、Wong-Baker 脸部疼痛评分量表[WBS]）以及呼吸频率（RR）、外周血氧饱和度和心率值的变化，以确定各组之间的差异。结果第一组和第二组与对照组相比，治疗后的问卷评分、呼吸频率、哭泣持续时间和疗效均有显著差异。第 1 组和第 2 组在治疗后的心率方面有明显差异，但在其他参数方面没有观察到差异。结论在吸入器治疗过程中使用 VR 眼镜有可能将疼痛等不良反应降至最低，并提高患者治疗环境的整体舒适度。

{"title":"Investigating the effect of virtual reality glasses during inhaler therapy use in children: A randomized clinical trial","authors":"Berker Okay, Zeynep Üze Okay","doi":"10.1093/pch/pxae020","DOIUrl":"https://doi.org/10.1093/pch/pxae020","url":null,"abstract":"Objectives Virtual reality (VR) glasses have been used in the medical field, as they are perceived to be suitable for distracting children. In this study, we aimed to compare patients who received inhaler treatment with VR glasses with those who received treatment without the aid of any device in terms of treatment compliance. Materials and Methods A prospective, randomized controlled study was conducted on pediatric patients aged 2 to 5 years requiring inhaler treatment (salbutamol), with the informed consent of their families. Participating patients who received standard care were divided into three groups via randomization: roller coaster VR group, wild dolphin VR group, and no additional device group. The patients were observed during their 15-minute inhaler treatment, and the groups were compared in terms of crying times, pre- and post-treatment physician and family questionnaire data (Face, Legs, Activity, Cry, Consolabity Scale [FLACC], Modified Yale Anxiety Scale [MYPAS], Modifiye Parents’ Pain Measure [MPMM], Wong–Baker Faces Pain Rating Scale [WBS]), and respiratory rate (RR), peripheral oxygen saturation, and heart rate value changes to determine any differences between them. Results Post-treatment questionnaire scores, RR, crying duration, and efficacy of treatment exhibited significant differences in Groups 1 and 2 compared to the control group. A significant difference was found in the post-treatment RR between groups 1 and 2, but no difference was observed in the other parameters. Conclusions Utilizing VR glasses during inhaler therapy has the potential to minimize adverse effects, such as pain, and enhance the overall comfort of the treatment environment for patients.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"36 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141194249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reference gender-specific neonatal size at birth growth curves for singleton and twin neonates from North India. 北印度单胎和双胎新生儿出生时的参考性别特异新生儿体型生长曲线。

IF 1.8 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-04-11 eCollection Date: 2024-09-01 DOI: 10.1093/pch/pxae011

Ambalakkuthan Murugesan, Sushma Nangia, Arvind Saili

Objectives: To construct reference growth curves for the preterm population from North India and compare it with global charts.

Methods: This prospective study enrolled preterm neonates (23 to 36 weeks) from July 2018 to August 2019 after excluding stillbirths and those with congenital malformations. Anthropometry was performed within 18 hours of birth. Gestation age was assessed by the best estimate of a combination of the last menstrual period, antenatal first-trimester ultrasound, and Expanded New Ballard Score (ENBS). Centile curves were constructed for both genders for twins and singleton neonates separately using the GAMLSS method using R software.

Results: During the study period, of the 14,908 births, 3253 (21.8%) were born preterm. After excluding malformations and stillbirths, 2976 preterm neonates were eligible, out of which anthropometry within 18 hours was done for 2719 neonates. Data was analyzed for 2290 singleton and 414 twin preterm neonates. Smoothed reference growth curves were constructed for all anthropometric parameters for both genders for singleton as well as twin neonates. Indian preterm infants were smaller compared to international standards. The proportion of small for gestational age (SGA) neonates was 23.1% (Fenton's charts) but only 10.9% when the data from the newly constructed chart was used. The concordance with international standards was better for very preterm neonates <32 weeks than moderate and late preterm neonates (32 to 36 weeks).

Conclusions: The reference charts derived from the present study can be used for the North Indian preterm population. The use of western growth charts tends to overestimate the incidence of SGA.

目标：为北印度早产儿构建参考生长曲线，并与全球图表进行比较：构建北印度早产儿的参考生长曲线，并与全球图表进行比较：这项前瞻性研究于 2018 年 7 月至 2019 年 8 月期间招募了早产新生儿（23 至 36 周），并排除了死胎和先天畸形儿。在新生儿出生 18 小时内进行人体测量。孕龄根据末次月经、产前第一胎超声检查和扩展新巴拉德评分（ENBS）组合的最佳估计值进行评估。利用 R 软件中的 GAMLSS 方法，分别构建了双胞胎和单胎新生儿的两性百分位曲线：在研究期间，14908 名新生儿中有 3253 名（21.8%）为早产儿。在排除畸形儿和死胎后，有 2976 名早产儿符合条件，其中有 2719 名新生儿在 18 小时内进行了人体测量。对 2290 名单胎早产儿和 414 名双胎早产儿的数据进行了分析。为单胎和双胎新生儿的所有男女人体测量参数构建了平滑参考生长曲线。与国际标准相比，印度早产儿体型较小。胎龄小的新生儿（SGA）比例为 23.1%（芬顿图表），而使用新构建的图表数据时，这一比例仅为 10.9%。极早产新生儿与国际标准的一致性更好：本研究得出的参考图表可用于北印度早产儿。使用西方的生长图表往往会高估 SGA 的发生率。

{"title":"Reference gender-specific neonatal size at birth growth curves for singleton and twin neonates from North India.","authors":"Ambalakkuthan Murugesan, Sushma Nangia, Arvind Saili","doi":"10.1093/pch/pxae011","DOIUrl":"10.1093/pch/pxae011","url":null,"abstract":"Objectives: To construct reference growth curves for the preterm population from North India and compare it with global charts.Methods: This prospective study enrolled preterm neonates (23 to 36 weeks) from July 2018 to August 2019 after excluding stillbirths and those with congenital malformations. Anthropometry was performed within 18 hours of birth. Gestation age was assessed by the best estimate of a combination of the last menstrual period, antenatal first-trimester ultrasound, and Expanded New Ballard Score (ENBS). Centile curves were constructed for both genders for twins and singleton neonates separately using the GAMLSS method using R software.Results: During the study period, of the 14,908 births, 3253 (21.8%) were born preterm. After excluding malformations and stillbirths, 2976 preterm neonates were eligible, out of which anthropometry within 18 hours was done for 2719 neonates. Data was analyzed for 2290 singleton and 414 twin preterm neonates. Smoothed reference growth curves were constructed for all anthropometric parameters for both genders for singleton as well as twin neonates. Indian preterm infants were smaller compared to international standards. The proportion of small for gestational age (SGA) neonates was 23.1% (Fenton's charts) but only 10.9% when the data from the newly constructed chart was used. The concordance with international standards was better for very preterm neonates <32 weeks than moderate and late preterm neonates (32 to 36 weeks).Conclusions: The reference charts derived from the present study can be used for the North Indian preterm population. The use of western growth charts tends to overestimate the incidence of SGA.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"29 6","pages":"367-373"},"PeriodicalIF":1.8,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11557136/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142625638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The management of very mild and mild asthma in preschoolers, children, and adolescents 学龄前儿童、儿童和青少年极轻微和轻度哮喘的管理

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-04-05 DOI: 10.1093/pch/pxae006

Connie L Yang, Zofia Zysman-Colman, Estelle Chétrit, Anne Hicks, Joseph Reisman, Amy Glicksman

This practice point summarizes recommendations from the Canadian Thoracic Society’s 2021 “Guideline update: Diagnosis and management of asthma in preschoolers, children, and adults.” New recommendations include: a decrease in the frequency of daytime symptoms and reliever use to ≤2 per week in the asthma control criteria; assessing for risk of asthma exacerbation; not using as-needed short-acting beta-agonists alone in patients at higher risk for exacerbation; and the option of as-needed budesonide/formoterol (bud/form) in those ≥12 years old if they are unable to take daily inhaled corticosteroids despite extensive asthma education and support. The preference for daily inhaled corticosteroids to manage mild asthma in children, and the recommendation against intermittent short courses of inhaled corticosteroids, are unchanged.

本实践要点总结了加拿大胸科学会 2021 年发布的 "指南更新：学龄前儿童、儿童和成人哮喘的诊断和管理 "中的建议。新建议包括：将哮喘控制标准中的日间症状和缓解剂使用频率降至每周≤2次；评估哮喘加重风险；对于哮喘加重风险较高的患者，不单独使用按需短效β-受体激动剂；对于≥12岁的患者，如果他们在接受大量哮喘教育和支持后仍无法每天吸入皮质类固醇，则可选择按需使用布地奈德/福莫特罗（bud/form）。在管理儿童轻度哮喘时，优先选择每日吸入皮质类固醇，以及建议不要间歇性短期吸入皮质类固醇的做法不变。

引用次数: 0

La prise en charge de l’asthme léger et très léger chez les enfants d’âge préscolaire, les enfants et les adolescents 学龄前儿童、儿童和青少年轻度和极轻度哮喘的管理

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-04-05 DOI: 10.1093/pch/pxae005

Connie L Yang, Zofia Zysman-Colman, Estelle Chétrit, Anne Hicks, Joseph Reisman, Amy Glicksman

Résumé Le présent point de pratique résume la mise à jour des lignes directrices de la Société canadienne de thoracologie publiée en 2021 sur le diagnostic et la prise en charge de l’asthme chez les enfants d’âge préscolaire, les enfants et les adultes. Ces nouvelles recommandations incluent, parmi les critères de contrôle de l’asthme, une diminution de la fréquence des symptômes diurnes et de l’utilisation de médicaments pour soulager l’asthme à un maximum de deux fois par semaine. Elles comprennent également l’évaluation du risque d’exacerbation de l’asthme, la non-utilisation de bêta-agonistes à courte durée d’action seuls au besoin chez les patients à plus fort risque d’exacerbation et la possibilité d’administrer du budésonide-formotérol au besoin aux jeunes de 12 ans ou plus qui sont incapables de prendre des corticostéroïdes inhalés au quotidien malgré une éducation sur l’asthme et un soutien importants. La préférence pour la prise quotidienne de corticostéroïdes inhalés afin de traiter l’asthme léger chez les enfants et la recommandation d’éviter les courts traitements intermittents de corticostéroïdes inhalés ne changent pas.

摘要本实践要点总结了加拿大胸科学会于 2021 年发布的关于学龄前儿童、儿童和成人哮喘诊断与管理的最新指南。在控制哮喘的标准中，这些新建议包括减少白天症状出现的频率，以及每周最多使用两次药物缓解哮喘。这些建议还包括对哮喘恶化风险的评估、对哮喘恶化风险较高的患者不按要求单独使用短效β-激动剂，以及对尽管接受了大量哮喘教育和支持但仍无法每天吸入皮质类固醇的 12 岁或以上青少年按要求使用布地奈德-福莫特罗的可能性。每日使用吸入皮质类固醇治疗儿童轻度哮喘的偏好以及避免间歇性短期使用吸入皮质类固醇的建议保持不变。

{"title":"La prise en charge de l’asthme léger et très léger chez les enfants d’âge préscolaire, les enfants et les adolescents","authors":"Connie L Yang, Zofia Zysman-Colman, Estelle Chétrit, Anne Hicks, Joseph Reisman, Amy Glicksman","doi":"10.1093/pch/pxae005","DOIUrl":"https://doi.org/10.1093/pch/pxae005","url":null,"abstract":"Résumé Le présent point de pratique résume la mise à jour des lignes directrices de la Société canadienne de thoracologie publiée en 2021 sur le diagnostic et la prise en charge de l’asthme chez les enfants d’âge préscolaire, les enfants et les adultes. Ces nouvelles recommandations incluent, parmi les critères de contrôle de l’asthme, une diminution de la fréquence des symptômes diurnes et de l’utilisation de médicaments pour soulager l’asthme à un maximum de deux fois par semaine. Elles comprennent également l’évaluation du risque d’exacerbation de l’asthme, la non-utilisation de bêta-agonistes à courte durée d’action seuls au besoin chez les patients à plus fort risque d’exacerbation et la possibilité d’administrer du budésonide-formotérol au besoin aux jeunes de 12 ans ou plus qui sont incapables de prendre des corticostéroïdes inhalés au quotidien malgré une éducation sur l’asthme et un soutien importants. La préférence pour la prise quotidienne de corticostéroïdes inhalés afin de traiter l’asthme léger chez les enfants et la recommandation d’éviter les courts traitements intermittents de corticostéroïdes inhalés ne changent pas.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"116 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140582151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Medical cannabis for children: Evidence and recommendations 儿童医用大麻：证据和建议

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-04-05 DOI: 10.1093/pch/pxad078

Lauren E Kelly, Michael J Rieder, Yaron Finkelstein

Interest in using cannabis products for a medical purpose in children under the age of 18 years is increasing. There are many medical cannabis products available that can include cannabidiol (CBD) or delta-9-tetrahydrocannabinol (THC), or both. Despite many therapeutic claims, there are few rigorous studies to inform the dosing, safety, and efficacy of medical cannabis in paediatric clinical practice. This statement reviews the current evidence and provides recommendations for using medical cannabis in children. Longer-term (2-year) reports support the sustained tolerability and efficacy of cannabidiol therapy for patients with Lennox-Gastaut and Dravet syndromes. CBD-enriched cannabis extracts containing small amounts of THC have been evaluated in a small number of paediatric patients, and further research is needed to inform clinical practice guidelines. Given the widespread use of medical cannabis in Canada, paediatricians should be prepared to engage in open, ongoing discussions with families about its potential benefits and risks, and develop individualized plans that monitor efficacy, reduce harms, and mitigate drug–drug interactions.

18 岁以下儿童对使用大麻产品进行医疗的兴趣与日俱增。目前市面上有许多医用大麻产品，可包含大麻二酚（CBD）或δ-9-四氢大麻酚（THC），或两者兼有。尽管有许多治疗声称，但很少有严格的研究为儿科临床实践中医用大麻的剂量、安全性和疗效提供依据。本声明回顾了目前的证据，并就儿童使用医用大麻提出了建议。较长期（2 年）的报告支持大麻二酚疗法对伦诺-加斯陶特综合症和德拉沃综合症患者的持续耐受性和疗效。含有少量四氢大麻酚的富含大麻二酚的大麻提取物已在少数儿科患者中进行了评估，还需要进一步的研究来为临床实践指南提供信息。鉴于医用大麻在加拿大的广泛使用，儿科医生应做好准备，就其潜在的益处和风险与患者家属进行公开、持续的讨论，并制定个性化的计划，以监测疗效、减少危害并减轻药物间的相互作用。

引用次数: 0

Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants 关于儿童医用大麻的证据和建议

IF 1.9 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-04-05 DOI: 10.1093/pch/pxad077

Lauren E Kelly, Michael J Rieder, Yaron Finkelstein

Résumé L’intérêt envers l’utilisation des produits du cannabis à des fins médicales chez les enfants de moins de 18 ans augmente. De nombreux produits du cannabis à des fins médicales contiennent du cannabidiol, du delta-9-tétrahydrocannabinol ou ces deux produits. Malgré les nombreuses prétentions thérapeutiques, peu d’études rigoureuses guident la posologie, l’innocuité et l’efficacité du cannabis à des fins médicales en pédiatrie clinique. Le présent document de principes passe en revue les données probantes à jour et expose les recommandations sur l’utilisation du cannabis à des fins médicales chez les enfants. Les rapports à plus long terme (deux ans) souscrivent à la tolérabilité et à l’efficacité soutenues d’un traitement au cannabidiol chez les patients ayant le syndrome de Lennox-Gastaut ou le syndrome de Dravet. Les extraits de cannabis enrichis de cannabidiol qui renferment de petites quantités de delta-9-tétrahydrocannabinol ont été évalués auprès d’un petit nombre de patients d’âge pédiatrique, et d’autres recherches devront être réalisées pour éclairer les guides de pratique clinique. Étant donné l’utilisation répandue du cannabis à des fins médicales au Canada, les pédiatres devraient être prêts à participer à des échanges ouverts et continus avec les familles au sujet de ses avantages potentiels et de ses risques, ainsi qu’à préparer des plans individuels en vue d’en surveiller l’efficacité, de réduire les méfaits et de limiter les interactions médicamenteuses.

摘要 18 岁以下儿童将大麻产品用于医疗目的的兴趣与日俱增。许多医用大麻产品都含有大麻二酚、δ-9-四氢大麻酚或两种成分。尽管有许多治疗声称，但很少有严格的研究来指导医用大麻在儿科临床中的剂量、安全性和疗效。本立场声明回顾了当前的证据，并概述了对儿童使用医用大麻的建议。较长期的报告（两年）支持大麻二酚治疗 Lennox-Gastaut 综合症或 Dravet 综合症患者的持续耐受性和疗效。含有少量δ-9-四氢大麻酚的大麻二酚富集大麻提取物已在少数儿科患者中进行了评估，还需要进一步的研究来为临床实践指南提供信息。鉴于大麻在加拿大被广泛用于医疗目的，儿科医生应做好准备，参与与家庭就大麻的潜在益处和风险进行公开和持续的讨论，并制定个人计划以监测疗效、减少伤害和限制药物相互作用。

{"title":"Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants","authors":"Lauren E Kelly, Michael J Rieder, Yaron Finkelstein","doi":"10.1093/pch/pxad077","DOIUrl":"https://doi.org/10.1093/pch/pxad077","url":null,"abstract":"Résumé L’intérêt envers l’utilisation des produits du cannabis à des fins médicales chez les enfants de moins de 18 ans augmente. De nombreux produits du cannabis à des fins médicales contiennent du cannabidiol, du delta-9-tétrahydrocannabinol ou ces deux produits. Malgré les nombreuses prétentions thérapeutiques, peu d’études rigoureuses guident la posologie, l’innocuité et l’efficacité du cannabis à des fins médicales en pédiatrie clinique. Le présent document de principes passe en revue les données probantes à jour et expose les recommandations sur l’utilisation du cannabis à des fins médicales chez les enfants. Les rapports à plus long terme (deux ans) souscrivent à la tolérabilité et à l’efficacité soutenues d’un traitement au cannabidiol chez les patients ayant le syndrome de Lennox-Gastaut ou le syndrome de Dravet. Les extraits de cannabis enrichis de cannabidiol qui renferment de petites quantités de delta-9-tétrahydrocannabinol ont été évalués auprès d’un petit nombre de patients d’âge pédiatrique, et d’autres recherches devront être réalisées pour éclairer les guides de pratique clinique. Étant donné l’utilisation répandue du cannabis à des fins médicales au Canada, les pédiatres devraient être prêts à participer à des échanges ouverts et continus avec les familles au sujet de ses avantages potentiels et de ses risques, ainsi qu’à préparer des plans individuels en vue d’en surveiller l’efficacité, de réduire les méfaits et de limiter les interactions médicamenteuses.","PeriodicalId":19730,"journal":{"name":"Paediatrics & child health","volume":"23 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140582250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Improving patient-centred care in the emergency department: Implementation of a Sensory Toolkit for children with autism. 改善急诊科以患者为中心的护理：为自闭症儿童实施感官工具包。

IF 1.8 4区医学 Q2 PEDIATRICS

Paediatrics & child health

Pub Date : 2024-03-22 eCollection Date: 2024-07-01 DOI: 10.1093/pch/pxae010

Meagan A Roy, Ceilidh Kinlin, Myka Estes, Sarah J MacEachern

Emergency department (ED) visits for children with autism can present challenges due to the unique sensory needs of this population. This Quality Improvement (QI) project executed two Plan-Do-Study-Act (PDSA) cycles to create and implement a Sensory Toolkit in the ED for children with autism. Most caregivers (94%; n = 31/33) and healthcare providers (HCPs; 86%; n = 37/44) identified the need for sensory items in the ED. In PDSA Cycle 1, 100% of caregivers (n = 21) and HCPs (n = 3) agreed/strongly agreed that the ED Sensory Toolkit was helpful. In PDSA Cycle 2, 92% of caregivers (n = 12/13) and 100% of HCPs (n = 3) agreed/strongly agreed that they were helpful. The Sensory Toolkit was positively evaluated by caregivers of children with autism and HCPs during the child's visit to the ED. There is an opportunity to adapt the Sensory Toolkit for other EDs and areas of the hospital.

由于自闭症儿童独特的感官需求，急诊科（ED）的就诊可能会给他们带来挑战。本质量改进（QI）项目执行了两个 "计划-实施-研究-行动"（PDSA）周期，在急诊室为自闭症儿童创建并实施了感官工具包。大多数护理人员（94%；n = 31/33）和医疗保健提供者（HCPs；86%；n = 37/44）都认为急诊室需要感统工具包。在 PDSA 循环 1 中，100% 的照护者（n = 21）和医护人员（n = 3）同意/非常同意急诊室感统工具包很有帮助。在 PDSA 循环 2 中，92% 的护理人员（n = 12/13）和 100% 的高级保健人员（n = 3）同意/非常同意它们很有帮助。自闭症儿童的看护者和保健医生在儿童就诊期间对感统工具包给予了积极评价。有机会将感统工具包应用于其他急诊室和医院的其他区域。

引用次数: 0